Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.122.001267Source: DataRank Database

Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys is a research paper published in Journal of Pharmacology and Experimental Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.55)OA: bronzeTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Charles P. France ORCID,Lisa R. Gerak ORCID

Live enrichment

PubMed:36575032 PMC:PMC9976789 OpenAlex:https://openalex.org/W4313236960

NIDA NIH HHS

Grant: UG3 DA048387

NIDA NIH HHS

Grant: R01 DA048417

FWCI

1.55

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttps://jpet.aspetjournals.org/content/jpet/384/3/363.full.pdf

publisherhttps://jpet.aspetjournals.org/content/jpet/384/3/363.full.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022356524004099?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022356524004099?httpAccept=text/plain

publisherhttps://syndication.highwire.org/content/doi/10.1124/jpet.122.001267

Fields of Study

Opioid Use Disorder TreatmentNeurotransmitter Receptor Influence on BehaviorForensic Toxicology and Drug Analysis

MeSH Terms

Analgesics, OpioidAnimalsCinnamatesCocaineHeroinDose-Response Relationship, DrugFentanylMacaca mulattaMethamphetamineMorphine DerivativesNaltrexoneNarcotic AntagonistsOpioid-Related DisordersReceptors, Opioid, mu

Keywords

FentanylNaltrexoneHeroinOpioidPharmacologyMethamphetamineMedicineOpioid antagonistOpioid receptorMorphineAnesthesiaDrugReceptor(+)-NaloxoneInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being